Related Experiment Video
Updated: Dec 22, 2025

Performing and Processing FNA of Anterior Fat Pad for Amyloid
Published on: October 30, 2010
Diagnosing cardiac amyloidosis in every-day practice: A practical guide for the cardiologist
Maria Papathanasiou1,2, Alexander Carpinteiro3,2, Christoph Rischpler4,2
1Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center, University Hospital Essen, Hufelandstrasse 55, 45147 Essen, Germany.
Insights
Cardiac amyloidosis (CA) is an underdiagnosed cause of heart failure. This review focuses on diagnosing CA, particularly transthyretin (ATTR-CA), using current and emerging methods for better patient outcomes.
Area of Science:
- Cardiology
- Nephrology
- Hematology
Background:
- Cardiac amyloidosis (CA) is an increasingly recognized cause of heart failure and mortality.
- Underdiagnosis stems from low awareness and non-specific symptoms.
- CA involves extracellular deposition of misfolded protein fibrils, primarily transthyretin (ATTR) or immunoglobulin light chains (AL).
Purpose of the Study:
- To provide an overview of cardiac amyloidosis.
- To highlight current and emerging diagnostic modalities for CA.
- To present a diagnostic algorithm for suspected CA in clinical practice.
Main Methods:
- Literature review of CA prevalence, symptoms, and causes.
- Analysis of diagnostic tools, including imaging and biopsy.
- Development of a practical diagnostic algorithm.
Main Results:
- ATTR-CA is prevalent in older heart failure patients, while AL-CA is rarer.
- Early and accurate diagnosis is crucial for effective management.
- Emerging diagnostic techniques show promise for improved detection.
Conclusions:
- CA is a significant contributor to heart failure that requires increased clinical awareness.
- A systematic diagnostic approach is essential for timely identification.
- The proposed algorithm aids in evaluating patients with suspected cardiac amyloidosis.
Abstract:
Cardiac amyloidosis (CA) has emerged as a previously underestimated cause of heart failure and mortality. Underdiagnosis resulted mainly from unawareness of the true disease prevalence and the non-specific symptoms of the disease. CA results from extracellular deposition of misfolded protein fibrils, commonly derived from transthyretin (ATTR) or immunoglobulin light chains (AL). A significant proportion of older patients with heart failure and other extracardiac manifestations suffer from ATTR-CA, whereas AL-CA is still considered a rare disease. This article provides an overview of CA with a special focus on current and emerging diagnostic modalities. Furthermore, we provide a diagnostic algorithm for the evaluation of patients with suspected CA in every-day practice.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Myocarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy V: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Cardiomyopathy II: Dilated Cardiomyopathy

